BROADWOOD CAPITAL INC

USReporting entityDirector3 companies · 24mo

Transactions

564

Issuers

Buys / Sells

472/44

Last tx

13 Mar 2026

Behaviour

8 purchases reported after at least 12 months of silence — most recent on 19 Sept 2023.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Lineage Cell Therapeutics, Inc.	49,560,992	reported	27 Jan 2025	tx 40+29,694,715−22,759
STAAR SURGICAL CO	16,123,842	reported	13 Mar 2026	tx 216+6,390,075−1,438,999
Insight Molecular Diagnostics Inc.	6,244,405	reported	02 Oct 2024	tx 20+7,864,426−965,000
PALOMAR MEDICAL TECHNOLOGIES INC	2,898,296	reported	15 Nov 2012	tx 20+311,992

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 70 buys in history.

1 month

−0.2%

Sample70

Win rate (≥5%)17%

Hit rate (>0)49%

3 months

−4.4%

Sample70

Win rate (≥5%)29%

Hit rate (>0)31%

6 months

+3.0%

Sample64

Recent transactions

Date	Type	Issuer	Qty	Price
11 Mar 2026	PURCHASE	STAAR SURGICAL CO	54,764	17.52 USD
12 Mar 2026	PURCHASE	STAAR SURGICAL CO	299,432	18.12 USD
12 Mar 2026	PURCHASE	STAAR SURGICAL CO	0	0.00 USD
11 Mar 2026	PURCHASE	STAAR SURGICAL CO	0	0.00 USD
13 Mar 2026	PURCHASE	STAAR SURGICAL CO	0	0.00 USD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Lineage Cell Therapeutics, Inc.	49,560,992	reported	27 Jan 2025	tx 40+29,694,715−22,759
STAAR SURGICAL CO	16,123,842	reported	13 Mar 2026	tx 216+6,390,075−1,438,999
Insight Molecular Diagnostics Inc.	6,244,405	reported	02 Oct 2024	tx 20+7,864,426−965,000
PALOMAR MEDICAL TECHNOLOGIES INC	2,898,296	reported	15 Nov 2012	tx 20+311,992

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 70 buys in history.

1 month

−0.2%

Sample70

Win rate (≥5%)17%

Hit rate (>0)49%

3 months

−4.4%

Sample70

Win rate (≥5%)29%

Hit rate (>0)31%

6 months

+3.0%

Sample64

Recent transactions

Date	Type	Issuer	Qty	Price
11 Mar 2026	PURCHASE	STAAR SURGICAL CO	54,764	17.52 USD
12 Mar 2026	PURCHASE	STAAR SURGICAL CO	299,432	18.12 USD
12 Mar 2026	PURCHASE	STAAR SURGICAL CO	0	0.00 USD
11 Mar 2026	PURCHASE	STAAR SURGICAL CO	0	0.00 USD
13 Mar 2026	PURCHASE	STAAR SURGICAL CO	0	0.00 USD